HARVEY GROUP PRACTICE — All Prescriptions & Medications — Page 8
Practice Code: E82084 | ST. ALBANS, AL3 5HB
Showing results 351-400 of 605
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Bezafibrate | 44 | 2,482 | £477 | -18.3% ▼ |
| Valproic acid | 44 | 5,220 | £1.5K | -49.4% ▼ |
| Ondansetron hydrochloride | 44 | 1,505 | £456 | -9.3% ▼ |
| Carbomer 940/980 | 44 | 1,320 | £246 | -71.1% ▼ |
| 44 | 124 | £597 | +41.9% ▲ | |
| Tirzepatide | 43 | 58 | £5.4K | -77.9% ▼ |
| Alfacalcidol | 43 | 3,630 | £583 | -65.2% ▼ |
| 43 | 1,260 | £799 | +65.0% ▲ | |
| Goserelin acetate | 42 | 42 | £4.9K | -4.7% ▼ |
| 42 | 1,365 | £1.1K | +13.1% ▲ | |
| 42 | 304 | £283 | +323.6% ▲ | |
| 42 | 254 | £246 | +34.9% ▲ | |
| BeclometDiprop/Formoterol/Glycopyrronium (Corticosteroids) | 41 | 57 | £2.5K | -75.5% ▼ |
| Ketone blood testing reagents | 41 | 680 | £696 | -39.4% ▼ |
| 41 | 132 | £947 | +47.3% ▲ | |
| Urea | 40 | 13.4K | £643 | -40.1% ▼ |
| 40 | 365 | £150 | +38.1% ▲ | |
| Verapamil hydrochloride | 39 | 3,157 | £341 | -57.0% ▼ |
| Haloperidol | 39 | 1,250 | £1.5K | -18.1% ▼ |
| Travoprost | 39 | 210 | £220 | -17.2% ▼ |
| 39 | 965 | £268 | +16.9% ▲ | |
| Triptorelin embonate | 38 | 38 | £15.7K | +281.7% ▲ |
| Adapalene | 38 | 1,755 | £609 | +73.6% ▲ |
| Fosfomycin trometamol | 37 | 52 | £241 | +30.0% ▲ |
| Medroxyprogesterone acetate | 37 | 39 | £227 | -69.4% ▼ |
| Chlorhexidine gluconate | 37 | 7,360 | £101 | +68.5% ▲ |
| 37 | 6,700 | £257 | -71.8% ▼ | |
| Domperidone | 36 | 2,614 | £100 | +0.9% vs avg |
| Oral rehydration salts | 36 | 1,368 | £514 | +24.6% ▲ |
| Water for injection | 36 | 440 | £177 | +6.4% ▲ |
| 36 | 776 | £2.2K | -9.7% ▼ | |
| 36 | 1,171 | £83 | -27.9% ▼ | |
| Pivmecillinam hydrochloride | 35 | 633 | £334 | -33.3% ▼ |
| Canagliflozin | 35 | 1,772 | £2.2K | -75.6% ▼ |
| Terbinafine hydrochloride | 35 | 1,365 | £250 | -5.7% ▼ |
| 35 | 416 | £713 | +8.2% ▲ | |
| Nebivolol | 34 | 1,764 | £1.4K | -67.9% ▼ |
| Naftidrofuryl oxalate | 34 | 714 | £89 | +4.4% ▲ |
| Formoterol/glycopyrronium/budesonide | 34 | 46 | £1.9K | -43.5% ▼ |
| Exemestane | 34 | 1,042 | £327 | +4.6% ▲ |
| Tacrolimus | 34 | 1,260 | £989 | -36.9% ▼ |
| 34 | 780 | £1.4K | +3.6% ▲ | |
| Perampanel | 33 | 4,548 | £6.7K | +52.3% ▲ |
| Rasagiline mesilate | 33 | 1,484 | £902 | -11.2% ▼ |
| Insulin degludec | 33 | 157 | £1.6K | -70.0% ▼ |
| Denosumab | 33 | 33 | £6.0K | +21.3% ▲ |
| Hypromellose | 33 | 340 | £87 | -75.1% ▼ |
| Fluorouracil (Sunscreen) | 33 | 1,320 | £1.0K | -9.4% ▼ |
| 33 | 342 | £56 | -12.2% ▼ | |
| Cinnarizine | 32 | 2,892 | £134 | -31.6% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.